A New Jersey jury today ordered Johnson & Johnson (NYSE:JNJ) to pay $750M in punitive damages to four plaintiffs who claimed their use of the company's talc-based products caused a rare cancer.

Citing state law, the judge presiding over the trial said she would reduce the punitive award to $186.5M, or ~5x the $37.3M in compensatory damages awarded by a separate jury in the first phase of the case last year.

J&J said it will appeal the verdicts in both phases of the trial, citing "numerous legal errors that subjected the jury to irrelevant information and prevented them from hearing meaningful evidence."

READ FULL ARTICLE HERE